Stock Market Today, June: Super Micro Plan Sparks Dilution Debate
June brought a high-stakes move in AI infrastructure funding. Super Micro Computer announced a $7B equity financing p...
What Are The Best Cash Back Rewards Cards With No Fee
Learn about the best cash back rewards cards that come with no fees. Maximize your benefits today!
23,366 articles
Here Dirt-Cheap Tech Giant Sparks Buying Interest
A major software conglomerate trading at a low forward multiple reports a record quarter, driving renewed investor in...
Stock Market About Suffer? BoA Warns of Snapback Risk
Bank of America warns that the stock market about suffer a pullback as speculative excess collides with tighter polic...
What This Therapeutics Insider Signals Revenue Momentum
A high-profile insider sale at PTC Therapeutics coincides with a milestone for product revenue. This article breaks d...
Axogen (AXGN) 2025 Earnings: Key Takeaways for Investors
As Axogen prepares to report its Q4 2025 results, investors want clarity on growth, margins, and guidance. This artic...
Wayfair's Co-Founder Sells Company Shares: Buy or Sell
A Wayfair founder sold shares worth about $2.1 million in February 2026. This article breaks down what insider sellin...
Calydon Capital Dumps Million: ZoomInfo Stock Decline Deepens
A major hedge fund trimmed its ZoomInfo position by millions, fueling questions about the company's prospects. This a...
Handing Money Homeowners Want: NYC ADU Grants Explained
New York City is turning a neighborhood challenge into a funding opportunity. This guide explains how ADU grants and ...
CDL Delivers Capital Gains with Income as Rates Near 4.4%
As U.S. rates linger near 4.4%, the VictoryShares ETF CDL is drawing attention for its ability to blend dividend inco...
Thing Investors Should Know About Meta's New Subscription Strategy
Meta is betting big on subscriptions with Meta One to pair recurring revenue with AI capability. The thing investors ...
Mind Tech (Mind) 2027: A Deep-Dive Investing Outlook
Mind tech (mind) 2027 is shaping a new era for investors who seek durable growth in neurotech and digital mental heal...
Can’t Stop Buying This Dividend Juggernaut: ABBV Growth
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status